Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse MKT  >  ImmunoCellular Therapeutics Ltd    IMUC

 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse Mkt
08/24/2015 08/25/2015 08/26/2015 08/27/2015 08/28/2015 Date
0.38(c) 0.38(c) 0.39(c) 0.4(c) 0.41(c) Last
530 647 612 859 217 658 547 033 188 120 Volume
-7.32% 0.00% +2.63% +2.56% +2.50% Change
More quotes
Financials ($)
Sales 2015 -
EBIT 2015 -16,4 M
Net income 2015 -14,3 M
Debt 2015 -
Yield 2015 -
Sales 2016 -
EBIT 2016 -22,9 M
Net income 2016 -23,0 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 0
Capi. / Sales 2016 0
Capitalization 36,1 M
More Financials
Company
ImmunoCellular Therapeutics Ltd. is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers.ImmunoCellular has concluded a phase 2 trial of its lead product candidate, ICT-107, a dendritic cell-based immunotherapy targeting... 
More about the company
Latest news on IMMUNOCELLULAR THERAPEUTIC
08/26 IMMUNOCELLULAR THERAPEUTICS : Other Events, Financial Statements and Exhibits (f..
08/21 IMMUNOCELLULAR THERAPEUTICS : Issues Letter to Shareholders, Highlighting Progre..
08/20 IMMUNOCELLULAR THERAPEUTICS : Reaches Agreement with FDA on Special Protocol Ass..
08/17 IMMUNOCELLULAR THERAPEUTICS : Notice of Delisting or Failure to Satisfy a Contin..
08/14 IMMUNOCELLULAR THERAPEUTICS : Other Events, Financial Statements and Exhibits (f..
08/13 IMMUNOCELLULAR THERAPEUTICS : Reaches Agreement with FDA on Special Protocol Ass..
08/12 IMMUNOCELLULAR THERAPEUTICS : Announces Second Quarter 2015 Financial Results
08/07 IMMUNOCELLULAR THERAPEUTICS : Management's Discussion and Analysis of Financial ..
More news
Sector news : Biotechnology & Medical Research - NEC
08:01a QUINTILES TRANSNATIONAL : CEO to Present at UBS Best of Americas 2015 Conference
08/27 ACTELION : Additional data on selexipag (uptravi) and macitentan (opsumit) to be..
08/27 GENMAB A/S : Data Published in The New England Journal of Medicine Shows Daratum..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
08/13 FDA OK's protocol for ImmunoCellular's Phase 3 study of ICT-107 in glioblasto..
08/06 ImmunoCellular's (IMUC) CEO Andrew Gengos on Q1 2015 Results - Earnings Call ..
08/06 ImmunoCellular Therapeutics beats by $0.02
05/22 NEXT WEEK IN BIOTECH : Salix/Valeant PDUFA, ASCO, Brain Tumor Summit
05/19 Immunocellular Therapeutics amends license agreement with Cedars-Sinai


Comments 
Advertisement
Chart IMMUNOCELLULAR THERAPEUTIC
Duration : Period :
ImmunoCellular Therapeutic Technical Analysis Chart | IMUC | US4525361055 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions